Dissecting the role of mPFC dynorphin circuits in the modulation of different pain states
Project Number1RF1NS132920-01A1
Former Number1R01NS132920-01A1
Contact PI/Project LeaderSHEETS, PATRICK L
Awardee OrganizationINDIANA UNIVERSITY INDIANAPOLIS
Description
Abstract Text
PROJECT SUMMARY
The goal of this work is to identify pain-induced adaptations in the prefrontal cortical dynorphin / kappa-opioid
receptor system and the role this system plays in pain-induced mal-adaptive behavior and nociception. Chronic
pain drives adaptations in prefrontal cortical circuits and is hypothesized to increase bias towards aversive
experiences. Our preliminary data demonstrates that inhibitory and excitatory populations of prefrontal cortical
dynorphin neurons are activated and release dynorphin neuropeptide in response to aversive stimuli. However,
it is unclear whether prefrontal cortical dynorphin neuron activity and ensuing dynorphin release is impacted by
pain. To address this knowledge gap, we will perform ex-vivo electrophysiological procedures and in-vivo single
cell calcium imaging in freely moving mice to determine how pain influences activity of excitatory and inhibitory
prefrontal cortical dynorphin neurons and their responsivity to noxious stimuli and aversive stimuli. Moreover, we
will manipulate the activity of prefrontal cortical dynorphin neurons and release of dynorphin neuropeptides or
fast transmitters to determine whether enhanced prefrontal cortical dynorphin neuron activity and transmitter
release controls nociception and mal-adaptive affective behavior induced by pain. Taken together, this work will
identify how genetically-defined sub-populations of prefrontal cortical neurons and the opioid peptides or fast
excitatory and inhibitory transmitters they release influence negative affect induced by pain from the cellular to
in-vivo level of analysis. This work is of broad relevance as it elucidates basic principles by which neuropeptide-
expressing neurons in prefrontal cortical circuits control behavioral plasticity and delineate potentially new
therapeutic targets for the treatment of mal-adaptive affect and increased responsivity to noxious and aversive
stimuli associated with pain states.
Public Health Relevance Statement
PROJECT NARRATIVE
To date, science has not produced a detailed elucidation of the circuitry involved in the physiological
and emotional response to pain. The goal of this project is to identify the neural mechanisms through
which surgical and neuropathic pain alters circuit function dynorphin-expressing neurons in the medial
prefrontal cortex (mPFC). Because the mPFC is a key node in the emotional network of the brain,
findings from this project should produce critical knowledge regarding the affective dimension of pain
and pain disorders that could lead to novel strategies for analgesic therapies.
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
603007902
UEI
SHHBRBAPSM35
DKNHLK3NBPH7
DL9MTNNKWYR9
GY8GKRUWM7D5
HA48EWMJFV47
HCNBFNDANNV5
HCRDU7BNPZ13
HCWTYJ7KQ4U6
HEBLAL94JHP7
NKCRSKVJBXE3
TA1NYNZ27LQ7
WJJRCLJ936C8
X51WYC1QEPD7
XNBJV454V2W1
YCJNP5NJYCY1
YW8WNKKANDR9
625168166
N/A
Project Start Date
20-September-2024
Project End Date
31-August-2027
Budget Start Date
20-September-2024
Budget End Date
31-August-2027
Project Funding Information for 2024
Total Funding
$2,068,842
Direct Costs
$1,348,708
Indirect Costs
$720,134
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Neurological Disorders and Stroke
$2,068,842
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1RF1NS132920-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1RF1NS132920-01A1
Patents
No Patents information available for 1RF1NS132920-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1RF1NS132920-01A1
Clinical Studies
No Clinical Studies information available for 1RF1NS132920-01A1
News and More
Related News Releases
No news release information available for 1RF1NS132920-01A1
History
No Historical information available for 1RF1NS132920-01A1
Similar Projects
No Similar Projects information available for 1RF1NS132920-01A1